CLINICAL_TRIALS
trial_result
· 2023-05-24
Clinical Trial Update: A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes [Phase 3]
Summary
A Phase 3 clinical trial update for dulaglutide in Chinese participants with type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2023-05-24